Natera (NTRA) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

NTRA Stock Forecast

Natera stock forecast is as follows: an average price target of $120.92 (represents a -21.18% downside from NTRA’s last price of $153.42) and a rating consensus of 'Buy', based on 11 wall street analysts offering a 1-year stock forecast.

NTRA Price Target

The average price target for Natera (NTRA) is $120.92 based on 1-year price targets from 11 Wall Street analysts in the past 3 months, with a price target range of $182.00 to $54.00. This represents a potential -21.18% downside from NTRA's last price of $153.42.

NTRA Analyst Ratings

Buy

According to 11 Wall Street analysts, Natera's rating consensus is 'Buy'. The analyst rating breakdown for NTRA stock is 1 'Strong Buy' (9.09%), 10 'Buy' (90.91%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Natera Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Nov 13, 2024	Tycho Peterson	Jefferies	$182.00	$114.57	58.85%	18.63%
Nov 13, 2024	Catherine Ramsey Schulte	Robert W. Baird	$160.00	$114.57	39.65%	4.29%
Oct 29, 2024	Kyle Mikson	Canaccord Genuity	$150.00	$120.71	24.26%	-2.23%
Sep 13, 2024	Dave Westenberg	Piper Sandler	$150.00	$125.12	19.88%	-2.23%
Aug 27, 2024	Kyle Mikson	Canaccord Genuity	$145.00	$118.11	22.77%	-5.49%
Aug 13, 2024	Tejas Savant	Morgan Stanley	$132.00	$115.25	14.53%	-13.96%
Aug 09, 2024	Catherine Ramsey Schulte	Robert W. Baird	$120.00	$107.70	11.42%	-21.78%
Jun 25, 2024	Doug Schenkel	Wolfe Research	$135.00	$107.41	25.69%	-12.01%
Jun 03, 2024	Tycho Peterson	Jefferies	$142.00	$106.53	33.30%	-7.44%
May 14, 2024	David Westenberg	Piper Sandler	$120.00	$103.33	16.13%	-21.78%

Row per page

Go to

The latest Natera stock forecast, released on Nov 13, 2024 by Tycho Peterson from Jefferies, set a price target of $182.00, which represents a 58.85% increase from the stock price at the time of the forecast ($114.57), and a 18.63% increase from NTRA last price ($153.42).

Natera Price Target by Period

	1M	3M	12M
# Anlaysts	3	5	13
Avg Price Target	$164.00	$157.40	$138.31
Last Closing Price	$153.42	$153.42	$153.42
Upside/Downside	6.90%	2.59%	-9.85%

In the current month, the average price target of Natera stock is $164.00, according to 3 Wall Street analysts offering twelve months forecast. The average price target represents a 6.90% increase as opposed to Natera's last price of $153.42. This month's average price target is up 4.19% compared to last quarter, and up 18.57% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Nov 13, 2024	Jefferies	Buy	Buy	Hold
Oct 29, 2024	Canaccord Genuity	Buy	Buy	Hold
Oct 16, 2024	UBS	Buy	Buy	Hold
Sep 16, 2024	BTIG	Buy	Buy	Hold
Sep 13, 2024	UBS	Buy	Buy	Hold
Sep 13, 2024	Piper Sandler	Overweight	Overweight	Hold
Sep 10, 2024	Cowen & Co.	Buy	Buy	Hold
Aug 27, 2024	Canaccord Genuity	Buy	Buy	Hold
Aug 13, 2024	Morgan Stanley	Overweight	Overweight	Hold
Aug 09, 2024	UBS	Buy	Buy	Hold

Row per page

Go to

Natera's last stock rating was published by Jefferies on Nov 13, 2024. The company gave NTRA a "Buy" rating, the same as its previous rate.

Natera Financial Forecast

Natera Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	$268.31M	$261.40M	$241.76M	$217.25M	$210.64M	$198.20M	$194.13M	$173.03M	$158.12M	$142.03M	$152.32M	$112.38M	$98.14M	$86.47M	$94.01M	$83.24M	$77.91M
Avg Forecast	$560.07M	$537.05M	$522.66M	$503.75M	$467.42M	$456.44M	$440.12M	$423.31M	$404.21M	$361.43M	$343.00M	$316.31M	$300.00M	$259.27M	$241.67M	$227.13M	$215.57M	$206.66M	$193.67M	$176.56M	$168.59M	$151.89M	$128.78M	$114.37M	$106.61M	$87.26M	$73.11M	$85.06M	$77.84M	$73.45M
High Forecast	$588.40M	$564.22M	$549.11M	$529.24M	$491.07M	$479.54M	$462.39M	$442.43M	$422.35M	$361.57M	$343.00M	$332.31M	$312.84M	$259.27M	$253.90M	$238.62M	$226.47M	$206.66M	$193.67M	$176.56M	$168.59M	$151.89M	$128.78M	$114.37M	$106.61M	$87.26M	$73.11M	$85.06M	$77.84M	$73.45M
Low Forecast	$533.46M	$511.54M	$497.83M	$479.82M	$445.22M	$434.76M	$419.21M	$401.78M	$381.51M	$361.30M	$343.00M	$301.28M	$287.16M	$259.27M	$230.19M	$216.34M	$205.33M	$206.66M	$193.67M	$176.56M	$168.59M	$151.89M	$128.78M	$114.37M	$106.61M	$87.26M	$73.11M	$85.06M	$77.84M	$73.45M
# Analysts	6	4	4	6	4	3	7	9	9	4	7	4	9	4	6	4	3	7	4	3	4	7	4	4	13	8	8	9	12	7
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	1.03%	1.08%	1.06%	1.01%	1.02%	1.02%	1.10%	1.03%	1.04%	1.10%	1.33%	1.05%	1.12%	1.18%	1.11%	1.07%	1.06%

Natera's average Quarter revenue forecast for Dec 23 based on 9 analysts is $300.00M, with a low forecast of $287.16M, and a high forecast of $312.84M. NTRA's average Quarter revenue forecast represents a 11.81% increase compared to the company's last Quarter revenue of $268.31M (Sep 23).

Natera EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	6	4	4	6	4	3	7	9	9	4	7	4	9	4	6	4	3	7	4	3	4	7	4	4	13	8	8	9	12	7
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	$-105.58M	$-112.43M	$-133.72M	$-135.47M	$-113.82M	$-138.32M	$-133.18M	$-135.52M	$-145.93M	$-111.00M	$-59.10M	$-69.67M	$-51.85M	$-53.37M	$-31.06M	$-30.81M	$-18.45M
Avg Forecast	$-289.32M	$-277.43M	$-270.00M	$-260.23M	$-241.47M	$-235.79M	$-227.36M	$-218.68M	$-208.81M	$-186.71M	$-177.19M	$-164.42M	$-154.98M	$-133.94M	$-124.84M	$-149.47M	$-129.73M	$-112.49M	$-105.42M	$-135.88M	$-91.76M	$-82.68M	$-70.10M	$-75.32M	$-58.03M	$-47.50M	$-39.79M	$-37.16M	$-42.37M	$-39.98M
High Forecast	$-275.58M	$-264.26M	$-257.18M	$-247.87M	$-229.99M	$-224.59M	$-216.56M	$-207.56M	$-197.09M	$-186.64M	$-177.19M	$-131.54M	$-148.34M	$-133.94M	$-118.91M	$-119.58M	$-103.78M	$-112.49M	$-105.42M	$-108.71M	$-91.76M	$-82.68M	$-70.10M	$-60.26M	$-58.03M	$-47.50M	$-39.79M	$-29.73M	$-42.37M	$-39.98M
Low Forecast	$-303.96M	$-291.47M	$-283.66M	$-273.40M	$-253.68M	$-247.73M	$-238.87M	$-228.56M	$-218.18M	$-186.78M	$-177.19M	$-197.30M	$-161.61M	$-133.94M	$-131.16M	$-179.37M	$-155.67M	$-112.49M	$-105.42M	$-163.06M	$-91.76M	$-82.68M	$-70.10M	$-90.38M	$-58.03M	$-47.50M	$-39.79M	$-44.59M	$-42.37M	$-39.98M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.79%	0.90%	0.89%	1.04%	1.01%	1.31%	0.98%	1.48%	1.76%	1.58%	0.78%	1.20%	1.09%	1.34%	0.84%	0.73%	0.46%

undefined analysts predict NTRA's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Natera's previous annual EBITDA (undefined) of $NaN.

Natera Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	6	4	4	6	4	3	7	9	9	4	7	4	9	4	6	4	3	7	4	3	4	7	4	4	13	8	8	9	12	7
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	$-109.03M	$-110.80M	$-136.94M	$-142.57M	$-121.48M	$-145.15M	$-138.59M	$-140.56M	$-151.27M	$-116.03M	$-63.85M	$-76.41M	$-58.32M	$-59.64M	$-35.37M	$-35.18M	$-23.14M
Avg Forecast	$30.15M	$17.32M	$16.37M	$142.22K	$-30.61M	$-37.75M	$-42.49M	$-51.02M	$-61.27M	$-71.12M	$-85.25M	$-171.10M	$-95.29M	$-118.54M	$-134.63M	$-155.54M	$-134.56M	$-177.06M	$-184.23M	$-141.40M	$-160.85M	$-158.80M	$-138.03M	$-81.38M	$-76.41M	$-83.40M	$-72.69M	$-42.32M	$-67.74M	$-67.77M
High Forecast	$32.13M	$18.46M	$17.45M	$151.57K	$-28.72M	$-35.41M	$-39.87M	$-36.85M	$-56.06M	$-66.73M	$-79.98M	$-136.88M	$-87.46M	$-111.22M	$-126.31M	$-124.44M	$-107.64M	$-177.06M	$-184.23M	$-113.12M	$-160.85M	$-158.80M	$-138.03M	$-65.11M	$-76.41M	$-83.40M	$-72.69M	$-33.86M	$-67.74M	$-67.77M
Low Forecast	$28.28M	$16.25M	$15.36M	$133.44K	$-32.62M	$-40.23M	$-45.28M	$-59.52M	$-67.79M	$-75.80M	$-90.85M	$-205.32M	$-104.43M	$-126.34M	$-143.48M	$-186.65M	$-161.47M	$-177.06M	$-184.23M	$-169.69M	$-160.85M	$-158.80M	$-138.03M	$-97.66M	$-76.41M	$-83.40M	$-72.69M	$-50.78M	$-67.74M	$-67.77M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.92%	0.82%	0.88%	1.06%	0.69%	0.79%	0.98%	0.87%	0.95%	0.84%	0.78%	1.00%	0.70%	0.82%	0.84%	0.52%	0.34%

Natera's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. NTRA's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Natera SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	6	4	4	6	4	3	7	9	9	4	7	4	9	4	6	4	3	7	4	3	4	7	4	4	13	8	8	9	12	7
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	$154.74M	$152.51M	$149.63M	$143.82M	$147.67M	$149.47M	$147.63M	$146.76M	$128.49M	$127.46M	$108.33M	$94.08M	$75.68M	$68.19M	$65.68M	$58.59M	$56.72M
Avg Forecast	$399.24M	$382.84M	$372.58M	$359.10M	$333.20M	$325.38M	$313.74M	$301.75M	$288.14M	$257.65M	$244.51M	$182.26M	$213.86M	$184.82M	$172.27M	$165.69M	$140.49M	$147.32M	$138.06M	$150.63M	$120.18M	$108.28M	$91.80M	$81.53M	$76.00M	$62.20M	$52.11M	$78.58M	$55.49M	$52.36M
High Forecast	$419.44M	$402.21M	$391.43M	$377.27M	$350.06M	$341.84M	$329.61M	$315.39M	$301.07M	$257.75M	$244.51M	$218.71M	$223.01M	$184.82M	$180.99M	$198.83M	$168.58M	$147.32M	$138.06M	$180.75M	$120.18M	$108.28M	$91.80M	$81.53M	$76.00M	$62.20M	$52.11M	$94.30M	$55.49M	$52.36M
Low Forecast	$380.28M	$364.65M	$354.88M	$342.04M	$317.37M	$309.92M	$298.84M	$286.41M	$271.96M	$257.55M	$244.51M	$145.81M	$204.70M	$184.82M	$164.09M	$132.55M	$112.39M	$147.32M	$138.06M	$120.50M	$120.18M	$108.28M	$91.80M	$81.53M	$76.00M	$62.20M	$52.11M	$62.87M	$55.49M	$52.36M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.84%	0.89%	0.90%	1.02%	1.00%	1.08%	0.98%	1.22%	1.19%	1.39%	1.33%	1.24%	1.22%	1.31%	0.84%	1.06%	1.08%

Natera's average Quarter SG&A projection for Dec 23 is $213.86M, based on 9 Wall Street analysts, with a range of $204.70M to $223.01M. The forecast indicates a 38.20% rise compared to NTRA last annual SG&A of $154.74M (Sep 23).

Natera EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	6	4	4	6	4	3	7	9	9	4	7	4	9	4	6	4	3	7	4	3	4	7	4	4	13	8	8	9	12	7
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	$-0.95	$-0.97	$-1.23	$-1.45	$-1.25	$-1.50	$-1.45	$-1.52	$-1.63	$-1.32	$-0.74	$-0.94	$-0.72	$-0.75	$-0.45	$-0.45	$-0.33
Avg Forecast	$0.24	$0.14	$0.13	-	$-0.25	$-0.30	$-0.34	$-0.41	$-0.50	$-0.57	$-0.69	$-0.71	$-0.77	$-0.96	$-1.09	$-1.16	$-1.42	$-1.44	$-1.50	$-1.49	$-1.31	$-1.29	$-1.12	$-1.02	$-0.62	$-0.68	$-0.59	$-0.56	$-0.55	$-0.55
High Forecast	$0.26	$0.15	$0.14	-	$-0.23	$-0.29	$-0.32	$-0.30	$-0.45	$-0.54	$-0.65	$-0.66	$-0.71	$-0.90	$-1.02	$-1.08	$-1.33	$-1.44	$-1.50	$-1.49	$-1.31	$-1.29	$-1.12	$-1.02	$-0.62	$-0.68	$-0.59	$-0.56	$-0.55	$-0.55
Low Forecast	$0.23	$0.13	$0.12	-	$-0.26	$-0.33	$-0.37	$-0.48	$-0.55	$-0.61	$-0.73	$-0.75	$-0.84	$-1.02	$-1.16	$-1.23	$-1.52	$-1.44	$-1.50	$-1.49	$-1.31	$-1.29	$-1.12	$-1.02	$-0.62	$-0.68	$-0.59	$-0.56	$-0.55	$-0.55
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.99%	0.89%	1.06%	1.02%	0.87%	1.00%	0.98%	1.16%	1.26%	1.17%	0.73%	1.52%	1.06%	1.27%	0.80%	0.82%	0.60%

According to undefined Wall Street analysts, Natera's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to NTRA previous annual EPS of $NaN (undefined).

Natera Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
DRIO	DarioHealth	$0.80	$10.75	1243.75%	Buy
GTH	Genetron	$4.03	$10.00	148.14%	-
PSNL	Personalis	$3.59	$7.75	115.88%	Hold
GH	Guardant Health	$28.96	$57.27	97.76%	Buy
EXAS	Exact Sciences	$49.54	$89.67	81.01%	Buy
ILMN	Illumina	$130.74	$202.44	54.84%	Buy
NEO	NeoGenomics	$15.01	$23.00	53.23%	Buy
CSTL	Castle Biosciences	$27.90	$40.50	45.16%	Buy
CDNA	CareDx	$21.56	$29.75	37.99%	Buy
QGEN	Qiagen	$40.99	$51.89	26.59%	Buy
NEOG	Neogen	$15.20	$17.50	15.13%	Buy
TWST	Twist Bioscience	$41.43	$42.40	2.34%	Buy
NTRA	Natera	$153.42	$120.92	-21.18%	Buy

NTRA Forecast FAQ

Is Natera a good buy?

Yes, according to 11 Wall Street analysts, Natera (NTRA) is considered a 'Buy'. The rating consensus is based on 1 'Strong Buy' and 10 'Buy' recommendations, accounting for 100.00% of NTRA's total ratings.

What is NTRA's price target?

Natera (NTRA) average price target is $120.92 with a range of $54 to $182, implying a -21.18% from its last price of $153.42. The data is based on 11 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Natera stock go up soon?

According to Wall Street analysts' prediction for NTRA stock, the company can go down by -21.18% (from the last price of $153.42 to the average price target of $120.92), up by 18.63% based on the highest stock price target, and down by -64.80% based on the lowest stock price target.

Can Natera stock reach $200?

NTRA's average twelve months analyst stock price target of $120.92 does not support the claim that Natera can reach $200 in the near future.

What is Natera's current price target trend?

3 Wall Street analysts forecast a $164 price target for Natera (NTRA) this month, up 6.90% from its last price of $153.42. Compared to the last 3 and 12 months, the average price target increased by 2.59% and decreased by -9.85%, respectively.

What are Natera's analysts' financial forecasts?

Natera's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.79B (high $1.88B, low $1.7B), average EBITDA is $-923M (high $-879M, low $-969M), average net income is $-162M (high $-141M, low $-178M), average SG&A $1.27B (high $1.34B, low $1.21B), and average EPS is $-1.308 (high $-1.138, low $-1.435). NTRA's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $2.12B (high $2.23B, low $2.02B), average EBITDA is $-1.097B (high $-1.045B, low $-1.152B), average net income is $63.98M (high $68.19M, low $60.03M), average SG&A $1.51B (high $1.59B, low $1.44B), and average EPS is $0.517 (high $0.551, low $0.485).

Did the NTRA's actual financial results beat the analysts' financial forecasts?

Based on Natera's last annual report (Dec 2023), the company's revenue was $1.08B, beating the average analysts forecast of $1.03B by 5.30%. Apple's EBITDA was $-446M, missing the average prediction of $-563M by -20.77%. The company's net income was $-435M, missing the average estimation of $-504M by -13.73%. Apple's SG&A was $618.31M, missing the average forecast of $736.64M by -16.06%. Lastly, the company's EPS was $-3.78, missing the average prediction of $-3.971 by -4.80%. In terms of the last quarterly report (Sep 2023), Natera's revenue was $268.31M, beating the average analysts' forecast of $259.27M by 3.48%. The company's EBITDA was $-106M, missing the average prediction of $-134M by -21.18%. Natera's net income was $-109M, missing the average estimation of $-119M by -8.03%. The company's SG&A was $154.74M, missing the average forecast of $184.82M by -16.28%. Lastly, the company's EPS was $-0.95, missing the average prediction of $-0.958 by -0.81%